SCHEMBL8957450

SCHEMBL8957450

O=[N+]([O-])OCC1CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8957322 0.93 CCNA2 (0.41)
SCHEMBL23829716 0.90
SCHEMBL6438537 0.90 ALDH1A1 (0.40)
SCHEMBL9875012 0.90 ALDH1A1 (0.40)
Hydrochloric Acid SCHEMBL7808115 0.81 PRKCQ (0.31)
Hydrochloric Acid SCHEMBL7816475 0.81 MMP2 (0.33)
SCHEMBL9152348 0.80 ALDH1A1 (0.33)
SCHEMBL7817737 0.80 MMP2 (0.35)
SCHEMBL8260874 0.80 TDP1 (0.36)
Hydrochloric Acid SCHEMBL7816874 0.79 PLG (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9133150-B2 O-nitro compounds and pharmaceutical compositions including same ORBITAL ATK, INC. (US) 2015-09-15 US disclosed
US-20130309324-A1 O-NITRO COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS INCLUDING SAME RADIORX, INC., C/O INTERWEST VENTURE PARTNERS (US) 2013-11-21 US disclosed
US-8530681-B2 Pharmaceutical compositions of O-nitro compounds ALLIANT TECHSYSTEMS INC. (US) 2013-09-10 US disclosed
US-20120237615-A1 PHARMACEUTICAL COMPOSITIONS OF O-NITRO COMPOUNDS RADIORX, INC., C/O INTERWEST VENTURE PARTNERS (US) 2012-09-20 US disclosed
US-20070135380-A1 O-nitro compounds, pharmaceutical compositions thereof and uses thereof RADIORX, INC. (US) 2007-06-14 US disclosed
EP-0689435-A1 USE OF SUBSTITUTED ALKYL NITRATES FOR THE TREATMENT OF PATHOLOGICALLY INCREASED INTRA-OCULAR PRESSURE BYK NEDERLAND BV (NL) 1996-01-03 EP disclosed
WO-1994021248-A1 USE OF SUBSTITUTED ALKYL NITRATES FOR THE TREATMENT OF PATHOLOGICALLY INCREASED INTRA-OCULAR PRESSURE BYK NEDERLAND BV (NL) 1994-09-29 WO disclosed